Browse By: Country ι Category ι Latest Reports ι Tag
Home  »  Current Partnering

Current Partnering Market Research Reports

Current Partnering: The source of best practice for dealmakers

Current Partnering is the leading publisher of partnering deal terms and best practice for dealmakers. Report titles cover all aspects of partnering best practice and deal terms, providing users with the information and insight required to optimise their partnering activities. 



Global Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials
The report provides a detailed understanding and analysis of how and why companies enter Antibody partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors Antibody technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest antibody agreements announced in the healthcare sectors, covering: Antibodies Antibody-drug conjugates Monoclonal antibodies Murine mAb Chimeric mAb Humanized mAb Human aAb Polyclonal Antibodies Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect
Published Date: Nov 2016
Published By: Current Partnering

Price: $2995
Global Vaccine Partnering Terms and Agreements 2010-2016: Deal trends, players and financials
Trends in vaccine and adjuvant partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for vaccines This report contains a comprehensive listing of all vaccine partnering deals announced since January 2010, including financial terms where available, including over 1,000 links to online deal records of actual vaccine partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. The report takes readers through the vaccine deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currentl
Published Date: Nov 2016
Published By: Current Partnering

Price: $2995
Johnson & Johnson / Janssen Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide an orien
Published Date: Nov 2016
Published By: Current Partnering

Price: $1495
Merck KGaA / Merck Serono Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide an orien
Published Date: Nov 2016
Published By: Current Partnering

Price: $1495
Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2010- 2016
The report provides a detailed understanding and analysis of how, why and on what terms companies enter discovery stage partnering deals. These deals are discovery stage whereby the licensee obtains a right or an option right to license the licensors product or technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest discovery agreements announced in the healthcare sector. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the
Published Date: Oct 2016
Published By: Current Partnering

Price: $2995
Global Infectious Vaccines Partnering Terms and Agreements 2010 to 2016: Deal trends, players and financials
This report provides details of the latest infectious vaccines agreements announced in the healthcare sectors. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not. This report contains a comprehensive listing of all infectious vaccines partnering deals announced since January 2010, including financial terms where available, including over 600 links to online deal records of actual infectious vacci
Published Date: Oct 2016
Published By: Current Partnering

Price: $2995
Global Biomarker Partnering Terms and Agreements 2010-2016: Deal trends, players and financials
Trends in biomarker partnering deals Biomarker partnering agreement structure Biomarker partnering contract documents Top biomarker deals by value Most active biomarker dealmakers The Global Biomarker Partnering 2010-2016 report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter Biomarker partnering deals and also includes software technologies. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest Biomarker agreements announced in the healthcare sectors. A biomarker, or biological
Published Date: Oct 2016
Published By: Current Partnering

Price: $2995
Johnson & Johnson / Janssen Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide an orien
Published Date: Oct 2016
Published By: Current Partnering

Price: $1495
Merck KGaA / Merck Serono Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide an orien
Published Date: Oct 2016
Published By: Current Partnering

Price: $1495
Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010- 2016
This report provides details of the latest partnering deals which disclose a royalty rate, announced in the pharmaceutical, biotechnology and diagnostic sectors. The report provides details of partnering deals disclosing royalty rates from 2010 to 2016. The report provides an overview of how and why companies enter partnering deals where a royalty is payable upon commercialization of the compound or technology. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documen
Published Date: Sep 2016
Published By: Current Partnering

Price: $2995
Global Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials
This report provides details of the latest monoclonal antibody agreements announced in the healthcare sectors, covering: Monoclonal antibodies Murine mAb Chimeric mAb Humanized mAb Human aAb Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not. This report contains a comprehensive listing of all monoclonal antibody partnering deals announced since Jan 2010, including financial terms where availabl
Published Date: Sep 2016
Published By: Current Partnering

Price: $2995
Global Pharmacogenomics Partnering Terms and Agreements 2010 to 2016
The report provides a detailed understanding and analysis of how and why companies enter pharmacogenomics partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors pharmacogenomics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest Pharmacogenomics agreements announced in the healthcare sectors. Pharmacogenomics focusses on the influence of genetic variation on drug response in patients by correlating gene expression or single nucleotide polymorphisms with a drug’s efficacy or toxicity. Understanding the flexibility of a prospective partner’s negotiated deals terms provide
Published Date: Sep 2016
Published By: Current Partnering

Price: $2995
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials
Trends in cancer monoclonal antibody partnering deals Most active companies in cancer monoclonal antibody partnering Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer monoclonal antibody partnering contract documents Top cancer monoclonal antibody deals by value This report provides details of the latest Cancer monoclonal antibody agreements announced in the healthcare sectors. This report provides details of the latest antibody agreements announced in the healthcare sectors, covering: Monoclonal antibodies Murine mAb Chimeric mAb Humanized mAb Human aAb Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the
Published Date: Sep 2016
Published By: Current Partnering

Price: $2995
Global Autoimmune Partnering 2010-2016: Deal trends, players and financials
Trends in Autoimmune partnering deals Financial deal terms for headline, upfront and royalty by stage of development Autoimmune partnering agreement structure Autoimmune partnering contract documents Top Autoimmune deals by value Most active Autoimmune dealmakers Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element. The report takes readers through the comprehensive Autoimmune disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are curre
Published Date: Sep 2016
Published By: Current Partnering

Price: $2995
Johnson & Johnson / Janssen Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide an orien
Published Date: Sep 2016
Published By: Current Partnering

Price: $1495
Merck KGaA / Merck Serono Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide an orien
Published Date: Sep 2016
Published By: Current Partnering

Price: $1495
Global Big Pharma Partnering Terms and Agreements 2010-2016: Deal trends, players and financials
This report provides details of the latest Big Pharma agreements announced in the life sciences since 2010. The report takes the reader through a comprehensive review Big Pharma deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Big Pharma partnering deals. The report presents financial deal term values for Big Pharma deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals. The middle section of the report explores the leading dealmakers in the Big Pharma partnering field; both the leading deal values and most active Big Pharma dealmaker companies are reported allowing the reader
Published Date: Jul 2016
Published By: Current Partnering

Price: $2995
Global Academic and Non-Profit Partnering Terms and Agreements 2010-2016: Deal trends, players and financials
This report provides details of the latest Academic and Non-Profit agreements announced in the life sciences since 2010. The report takes the reader through a comprehensive review Academic and Non-Profit deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Academic and Non-Profit partnering deals. The report presents financial deal term values for Academic and Non-Profit deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals. The middle section of the report explores the leading dealmakers in the Academic and Non-Profit partnering field; both the leading deal values and most activ
Published Date: Jul 2016
Published By: Current Partnering

Price: $2995
Global Biotech Partnering Terms and Agreements 2010-2016: Deal trends, players and financials
This report provides details of the latest Biotech agreements announced in the life sciences since 2010. The report takes the reader through a comprehensive review Biotech deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Biotech partnering deals. The report presents financial deal term values for Biotech deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals. The middle section of the report explores the leading dealmakers in the Biotech partnering field; both the leading deal values and most active Biotech dealmaker companies are reported allowing the reader to see who is suc
Published Date: Jul 2016
Published By: Current Partnering

Price: $2995
Global Medical Device Partnering Terms and Agreements 2010-2016: Deal trends, players and financials
This report provides details of the latest Medical Device agreements announced in the life sciences since 2010. The report takes the reader through a comprehensive review Medical Device deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Medical Device partnering deals. The report presents financial deal term values for Medical Device deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals. The middle section of the report explores the leading dealmakers in the Medical Device partnering field; both the leading deal values and most active Medical Device dealmaker companies are repo
Published Date: Jul 2016
Published By: Current Partnering

Price: $2995
Global Pharmaceutical Partnering Terms and Agreements 2010-2016: Deal trends, players and financials
This report provides details of the latest Pharmaceutical agreements announced in the life sciences since 2010. The report takes the reader through a comprehensive review Pharmaceutical deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Pharmaceutical partnering deals. The report presents financial deal term values for Pharmaceutical deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals. The middle section of the report explores the leading dealmakers in the Pharmaceutical partnering field; both the leading deal values and most active Pharmaceutical dealmaker companies are repo
Published Date: Jul 2016
Published By: Current Partnering

Price: $2995
Global Animal Health Partnering Terms and Agreements 2010 to 2016
The report provides a detailed understanding and analysis of how and why companies enter Animal Health partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes. This report provides details of the latest Animal Health agreements announced in the life sciences since 2010. The report takes the reader through a comprehensive review Animal Health deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Animal Health partnering deals. The report presents financial deal term values for Animal Health deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse an
Published Date: Jul 2016
Published By: Current Partnering

Price: $1995
Johnson & Johnson - Janssen Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: Jul 2016
Published By: Current Partnering

Price: $1495
Merck KGaA - Merck Serono Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: Jul 2016
Published By: Current Partnering

Price: $1495
Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016
The report provides a detailed understanding and analysis of how and why companies enter M&A deals. The majority of deals are acquisitions whereby the acquirer acquires the target company in a cash and/or equity transaction. Merger and acquisition is a constant activity within the biopharma sector. In the past, biopharma companies have sought to merge or acquire competitor companies in order to achieve critical mass both in R&D and sales and marketing, thus ensuring continued growth and dominance in a highly competitive and global marketplace. In 1987, the largest ten companies were responsible for approximately twelve percent of global pharmaceutical sales. By 2002, this figure had become nearly fifty percent. This concentration was principally due to big pharma mega mergers. The
Published Date: Jun 2016
Published By: Current Partnering

Price: $2995
Global Antibiotics Partnering Terms and Agreements 2010 to 2016
Trends in antibiotics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Antibiotics partnering contract documents Top antibiotics deals by value The Global Antibiotics Partnering Terms and Agreements 2010 to 2016 report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter antibiotics partnering deals. The majority of deals are early development stage whereby the licensee obtains a right or an option right to license the licensors antibiotics technology or product candidates. These deals tend to be multicomponent, starting with collaborative R&D, and commercia
Published Date: Jun 2016
Published By: Current Partnering

Price: $2995
Global Bioinformatics Partnering Terms and Agreements 2010 to 2016
Trends in bioinformatics partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active deal makers Financial deal terms for bioinformatics The Global Bioinformatics Partnering Terms and Agreements 2010 to 2016 report provides comprehensive understanding and unprecedented access to the bioinformatics partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter bioinformatics partnering deals. The majority of deals are discovery stage whereby the licensee obtains a right or an option right to license the licensors bioinformatics technology. These deals tend to be multicomponent, starting with collaborati
Published Date: Jun 2016
Published By: Current Partnering

Price: $2995
Optimer Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Otsuka Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
PDL BioPharma Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Perrigo Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Pfizer Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Purdue Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Questcor Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Ranbaxy Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Regeneron Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Roche Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Sanofi Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
SciClone Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Seattle Genetics Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Servier Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Shionogi Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Shire Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Smith & Nephew Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Spectrum Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Stada Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Sun Pharmaceutical 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Swedish Orphan Biovitrum Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Syngenta Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Takeda Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Targacept Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Teva Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
The Medicines Company Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
UCB Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
United Therapeutics Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Valeant Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Vertex Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Viropharma Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Warner Chilcott Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Watson Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Zeltia Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Jazz Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Salix Pharmaceuticals Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Pharmacyclics Partnering Deals and Alliances 2010 to 2016
On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The report will be delivered in PDF format within 1 working day of receipt of order. If the CD-Rom version purchased, the report will be sent by courier using express service. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. The initial chapters of this report provide
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Bladder Cancer Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Brain Cancer Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Breast Cancer Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Cervical Cancer Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Colorectal Cancer Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Gastric Cancer Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Head and Neck Cancer Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Leukemia Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Liver Cancer Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Lung Cancer Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Lymphoma Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Melanoma Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Multiple Myeloma Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Ovarian Cancer Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Pancreatic Cancer Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Prostate Cancer Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Solid Tumor Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Cancer Symptoms Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Non-Small Cell Lung Cancer Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Non-Hodgkin Lymphoma Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Myocardial Infarction Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Hypertension Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Hypercholesterolemia Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Congestive Heart Failure Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Coronary Artery Disease Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Atherosclerosis Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Arrhythmia Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Thrombus Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Traumatic Brain Injury Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Pain Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Spinal Cord Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Multiple Sclerosis Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Motor Neurone Disease Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Migraine Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495
Global Epilepsy Partnering 2010 to 2016
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negoti
Published Date: May 2016
Published By: Current Partnering

Price: $1495

Back To Top